APA (7th ed.) Citation

Heikema, A. P., Jacobs, B. C., Horst-Kreft, D., Huizinga, R., Kuijf, M. L., Endtz, H. P., . . . Cutler, S. (2013). Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain- Barré syndrome and Miller Fisher syndrome. Clinical Microbiology & Infection, 19(2), E106. https://doi.org/10.1111/1469-0691.12073

Chicago Style (17th ed.) Citation

Heikema, A. P., B. C. Jacobs, D. Horst-Kreft, R. Huizinga, M. L. Kuijf, H. P. Endtz, J. N. Samsom, W. J. B. Wamel, and S. Cutler. "Siglec-7 Specifically Recognizes Campylobacter Jejuni Strains Associated with Oculomotor Weakness in Guillain- Barré Syndrome and Miller Fisher Syndrome." Clinical Microbiology & Infection 19, no. 2 (2013): E106. https://doi.org/10.1111/1469-0691.12073.

MLA (9th ed.) Citation

Heikema, A. P., et al. "Siglec-7 Specifically Recognizes Campylobacter Jejuni Strains Associated with Oculomotor Weakness in Guillain- Barré Syndrome and Miller Fisher Syndrome." Clinical Microbiology & Infection, vol. 19, no. 2, 2013, p. E106, https://doi.org/10.1111/1469-0691.12073.